Key Challenges in the Latin American Cold Chain
Add bookmark
The loss of patent protection on top-selling medicines has slowed the sales growth of Pharmaceutical and Biotech companies in the U.S. and Europe. The market in Latin America, however, is booming and is currently growing two to three times faster than the U.S. and Europe and will surge to $124 billion by 2018.
Given this knowledge, we have identified the main challenges of the cold chain in Latin America in this handy infographic.
[inlinead]
 | Have Your Say Rate this feature and give us your feedback in the comments section below |
